Stratec SE (LON:0RAR)
25.73
+0.08 (0.29%)
At close: Sep 4, 2025
Stratec SE Revenue
Stratec SE had revenue of 59.30M EUR in the quarter ending June 30, 2025, a decrease of -4.08%. This brings the company's revenue in the last twelve months to 263.52M, up 2.10% year-over-year. In the year 2024, Stratec SE had annual revenue of 257.62M, down -4.73%.
Revenue (ttm)
263.52M EUR
Revenue Growth
+2.10%
P/S Ratio
1.23
Revenue / Employee
189.99K EUR
Employees
1,387
Market Cap
278.96M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 257.62M | -12.79M | -4.73% |
Dec 31, 2023 | 270.41M | -4.21M | -1.53% |
Dec 31, 2022 | 274.63M | -12.71M | -4.42% |
Dec 31, 2021 | 287.34M | 37.24M | 14.89% |
Dec 31, 2020 | 250.10M | 35.94M | 16.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |